Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
William BoisseauPhilipp EuskirchenKarima MokhtariCaroline DehaisMehdi TouatKhê Hoang-XuanMarc SansonLaurent CapelleAurélien NouetCarine KarachiFranck BielleJustine GuéganYannick MarieNadine Martin-DuverneuilLuc TaillandierAudrey RousseauJean-Yves DelattreAhmed IdbaihPublished in: The oncologist (2019)
Astroblastoma (ABM) remains a poorly defined and controversial entity. Although meningioma 1 alterations seem to define a large subset of pediatric cases, adult cases remain molecularly poorly defined. This comprehensive molecular characterization of 1 adolescent and 14 adult ABM revealed that adult ABM histology comprises several molecularly defined entities, which explains clinical diversity and identifies actionable targets. Namely, pleomorphic xanthoastrocytoma-like ABM cases show a favorable prognosis whereas high-grade glioma (glioblastoma and diffuse midline gliome)-like ABM show significantly worse clinical courses. These results call for in-depth molecular analysis of adult gliomas with astroblastic features for diagnostic and therapeutic purposes.